BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22652616)

  • 1. A critique of the DSM-5 field trials.
    Jones KD
    J Nerv Ment Dis; 2012 Jun; 200(6):517-9. PubMed ID: 22652616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the DSM-5: changes, controversy, and implications for psychiatric nursing.
    Halter MJ; Rolin-Kenny D; Dzurec LC
    J Psychosoc Nurs Ment Health Serv; 2013 Apr; 51(4):30-9. PubMed ID: 23451735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should prolonged grief be reclassified as a mental disorder in DSM-5?: reconsidering the empirical and conceptual arguments for complicated grief disorder.
    Wakefield JC
    J Nerv Ment Dis; 2012 Jun; 200(6):499-511. PubMed ID: 22652615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving toward DSM-5: the field trials.
    Kraemer HC; Kupfer DJ; Narrow WE; Clarke DE; Regier DA
    Am J Psychiatry; 2010 Oct; 167(10):1158-60. PubMed ID: 20889660
    [No Abstract]   [Full Text] [Related]  

  • 5. A distinct language and a historic pendulum: the evolution of the Diagnostic and Statistical Manual of Mental Disorders.
    Sanders JL
    Arch Psychiatr Nurs; 2011 Dec; 25(6):394-403. PubMed ID: 22114794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues for DSM-V: DSM-V should include a conceptual issues work group.
    Kendler KS; Appelbaum PS; Bell CC; Fulford KW; Ghaemi SN; Schaffner KF; Waterman GS; First MB; Sadler JZ
    Am J Psychiatry; 2008 Feb; 165(2):174-5. PubMed ID: 18245185
    [No Abstract]   [Full Text] [Related]  

  • 7. Dimensional approaches to psychiatric diagnosis in DSM-5.
    Narrow WE; Kuhl EA
    J Ment Health Policy Econ; 2011 Dec; 14(4):197-200. PubMed ID: 22345361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in operationalizing the DSM-IV clinical significance criterion.
    Beals J; Novins DK; Spicer P; Orton HD; Mitchell CM; Barón AE; Manson SM; Big Crow CK; Buchwald D; Chambers B; Christensen ML; Dillard DA; DuBray K; Espinoza PA; Flemming CM; Frederick AW; Gurley D; Jervis LL; Jim SM; Kaufman CE; Keane EM; Klein SA; Lee D; McNutly MC; Middlebrook DL; Moore LA; Nez TD; Norton IM; Randall CJ; Sam A; Shore JH; Simpson SG; Yazzie LL;
    Arch Gen Psychiatry; 2004 Dec; 61(12):1197-207. PubMed ID: 15583111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensional versus categorical classification of mental disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and beyond: comment on the special section.
    Brown TA; Barlow DH
    J Abnorm Psychol; 2005 Nov; 114(4):551-6. PubMed ID: 16351377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of mental disorders: the problem of reification.
    Hyman SE
    Annu Rev Clin Psychol; 2010; 6():155-79. PubMed ID: 17716032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues for DSM-V: the role of culture in psychiatric diagnosis.
    Alarcón RD; Becker AE; Lewis-Fernández R; Like RC; Desai P; Foulks E; Gonzales J; Hansen H; Kopelowicz A; Lu FG; Oquendo MA; Primm A;
    J Nerv Ment Dis; 2009 Aug; 197(8):559-660. PubMed ID: 19684490
    [No Abstract]   [Full Text] [Related]  

  • 12. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5.
    Narrow WE; Clarke DE; Kuramoto SJ; Kraemer HC; Kupfer DJ; Greiner L; Regier DA
    Am J Psychiatry; 2013 Jan; 170(1):71-82. PubMed ID: 23111499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.
    Nunes EV; Rounsaville BJ
    Addiction; 2006 Sep; 101 Suppl 1():89-96. PubMed ID: 16930164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Director of top research organization for mental health criticizes DSM for lack of validity.
    McCarthy M
    BMJ; 2013 May; 346():f2954. PubMed ID: 23657190
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of developmental field trials in the revision of psychiatric classifications.
    First MB
    Lancet Psychiatry; 2016 Jun; 3(6):579-84. PubMed ID: 27133547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DSM-IV].
    Pull CB
    Encephale; 1995 Dec; 21 Spec No 5():15-20. PubMed ID: 8582301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative hierarchical organization of the mental disorders of the DSM-IV.
    Flanagan EH; Keeley J; Blashfield RK
    J Abnorm Psychol; 2008 Aug; 117(3):693-8. PubMed ID: 18729621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How culture is assessed in the DSM-5.
    Warren BJ
    J Psychosoc Nurs Ment Health Serv; 2013 Apr; 51(4):40-5. PubMed ID: 23451737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DSM-III: the 3d edition of the Diagnostic and Statistical Manual of Mental Disorders from the American Psychiatric Association].
    Pichot P
    Rev Neurol (Paris); 1986; 142(5):489-99. PubMed ID: 3787052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.